Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma
- Mateos, M.-V.
- Rigaudeau, S.
- Basu, S.
- Spicka, I.
- Schots, R.
- Wrobel, T.
- Cook, G.
- Beksac, M.
- Gries, K.S.
- Kudva, A.
- Tromp, B.
- Van Rampelbergh, R.
- Pei, H.
- Wroblewski, S.
- Carson, R.
- Delioukina, M.
- White, D.
ISSN: 1477-092X, 1078-1552
Year of publication: 2023
Volume: 29
Issue: 5
Pages: 1172-1177
Type: Article